Study the effect of vana tulsi in seizure disorder.
Phase 1
- Conditions
- Health Condition 1: G40- Epilepsy and recurrent seizures
- Registration Number
- CTRI/2021/07/035018
- Lead Sponsor
- Dr Anita Chandravanshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
(1)Patient with clinical manifestation of disease.
(2)Age group 5 to 16 years
(3)Patient who were previously diagnosed and have reliable reports.
Exclusion Criteria
(1) Onset of seizure.
(2) Patient below 5 years and above 16 years.
(3) progressive neurological disease.
(4) Systemic illness like heart, renal, hepatic diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparing the severity and frequency of seizure before and after intervention.Timepoint: At the end of 9 months
- Secondary Outcome Measures
Name Time Method Change in subjective and objective parameters after treatment.Timepoint: At the end of 9 months.